BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22309680)

  • 1. Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry.
    Zhang T; Wu X; Yin M; Fan L; Zhang H; Zhao F; Zhang W; Ke C; Zhang G; Hou Y; Zhou X; Lou G; Li K
    Clin Chim Acta; 2012 May; 413(9-10):861-8. PubMed ID: 22309680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
    Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
    Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling.
    Zhang T; Wu X; Ke C; Yin M; Li Z; Fan L; Zhang W; Zhang H; Zhao F; Zhou X; Lou G; Li K
    J Proteome Res; 2013 Jan; 12(1):505-12. PubMed ID: 23163809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale profiling of metabolic dysregulation in ovarian cancer.
    Ke C; Hou Y; Zhang H; Fan L; Ge T; Guo B; Zhang F; Yang K; Wang J; Lou G; Li K
    Int J Cancer; 2015 Feb; 136(3):516-26. PubMed ID: 24895217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Li Y; Song X; Zhao X; Zou L; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS).
    Kim JY; Park JY; Kim OY; Ham BM; Kim HJ; Kwon DY; Jang Y; Lee JH
    J Proteome Res; 2010 Sep; 9(9):4368-75. PubMed ID: 20560578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling.
    Zhang H; Ge T; Cui X; Hou Y; Ke C; Yang M; Yang K; Wang J; Guo B; Zhang F; Lou G; Li K
    Mol Biosyst; 2015 Feb; 11(2):516-21. PubMed ID: 25424060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid mass spectrometric metabolic profiling of blood sera detects ovarian cancer with high accuracy.
    Zhou M; Guan W; Walker LD; Mezencev R; Benigno BB; Gray A; Fernández FM; McDonald JF
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2262-71. PubMed ID: 20699376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct urinary metabolic profile of human colorectal cancer.
    Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
    J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary metabolic profiling of colorectal carcinoma based on online affinity solid phase extraction-high performance liquid chromatography and ultra performance liquid chromatography-mass spectrometry.
    Wang W; Feng B; Li X; Yin P; Gao P; Zhao X; Lu X; Zheng M; Xu G
    Mol Biosyst; 2010 Oct; 6(10):1947-55. PubMed ID: 20617254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary hydrophilic and hydrophobic metabolic profiling based on liquid chromatography-mass spectrometry methods: Differential metabolite discovery specific to ovarian cancer.
    Chen J; Zhou L; Zhang X; Lu X; Cao R; Xu C; Xu G
    Electrophoresis; 2012 Nov; 33(22):3361-9. PubMed ID: 23109122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic profiling of rat serum associated with isoproterenol-induced myocardial infarction using ultra-performance liquid chromatography/time-of-flight mass spectrometry and multivariate analysis.
    Zhang HY; Chen X; Hu P; Liang QL; Liang XP; Wang YM; Luo GA
    Talanta; 2009 Jul; 79(2):254-9. PubMed ID: 19559874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
    Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
    J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic profiling of urine in young obese men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC/Q-TOF MS).
    Wang C; Feng R; Sun D; Li Y; Bi X; Sun C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2871-6. PubMed ID: 21890434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
    Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
    Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX; Wu Y; Han HQ; Wang QH
    Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.